Document Detail


Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia.
MedLine Citation:
PMID:  20671119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent in vitro studies provide evidence for autoantibody-induced suppression of megakaryocytopoiesis and show a reduction in megakaryocyte production and maturation in the presence of immune thrombocytopenia (ITP) plasma. Here, we present CD34(+) cells from healthy umbilical cord blood mononuclear cells cultured in medium containing thrombopoietin, stem cell factor, interleukin-3, and 10% plasma from either ITP patients or healthy subjects. The quantity, quality, and apoptosis of megakaryocytes were measured. We observed that most ITP plasma boosted megakaryocyte quantity but impaired quality, resulting in significantly less polyploidy cells (N ≥ 4) and platelet release. In these megakaryocytes, we found a lower percentage of cell apoptosis, a lower expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and a higher expression of Bcl-xL. Furthermore, there was a decrease of sTRAIL in ITP plasma and in cell culture supernatants of this group compared with the control group. Our findings suggest that decreased apoptosis of megakaryocytes also contributes to in vitro dysmegakaryocytopoiesis and reduced platelet production. The abnormal expression of sTRAIL in plasma and TRAIL and Bcl-xL in megakaryocytes may play a role in the pathogenesis of impaired megakaryocyte apoptosis in ITP.
Authors:
Lei Yang; Lin Wang; Chun-Hong Zhao; Xiao-Juan Zhu; Yu Hou; Peng Jun; Ming Hou
Related Documents :
15033719 - Restoration of trail-induced apoptosis in a caspase-8-deficient neuroblastoma cell line...
19483299 - Sensitization of human hepatic stellate cells to tumor necrosis factor-related apoptosi...
17510429 - The proteasome inhibitor ps-341 (bortezomib) up-regulates dr5 expression leading to ind...
11212279 - Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apopto...
19438509 - Reactive oxygen species up-regulate p53 and puma; a possible mechanism for apoptosis du...
17924059 - Pharmacological inhibition of bcl-2 family members reactivates trail-induced apoptosis ...
15331709 - Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional al...
11131909 - Glutathione depletion-induced neutrophil apoptosis is caspase 3 dependent.
20415849 - 99th dahlem conference on infection, inflammation and chronic inflammatory disorders: i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-29
Journal Detail:
Title:  Blood     Volume:  116     ISSN:  1528-0020     ISO Abbreviation:  Blood     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-22     Completed Date:  2010-12-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4307-16     Citation Subset:  AIM; IM    
Affiliation:
Hematology Oncology Centre, Qilu Hospital, Shandong University, Jinan, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Apoptosis*
Blood Platelets / pathology*
Caspase 3 / metabolism
Caspase 8 / metabolism
Cell Differentiation
Cells, Cultured
Cyclin B1 / metabolism
Cyclin D3 / metabolism
Female
Humans
Immunoglobulin G / immunology
Male
Megakaryocytes / enzymology,  pathology*
Middle Aged
Solubility
TNF-Related Apoptosis-Inducing Ligand / metabolism*
Thrombocytopenia / blood,  enzymology,  immunology*,  pathology*
Young Adult
bcl-X Protein / metabolism
Chemical
Reg. No./Substance:
0/Cyclin B1; 0/Cyclin D3; 0/Immunoglobulin G; 0/TNF-Related Apoptosis-Inducing Ligand; 0/TNFSF10 protein, human; 0/bcl-X Protein; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspase 8

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphop...
Next Document:  Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells.